STOCK TITAN

Immunic: OrbiMed Advisors reports 2.3% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Immunic, Inc. (IMUX) common stock is covered by amended beneficial-ownership reports from OrbiMed Advisors LLC, OrbiMed Genesis GP LLC and OrbiMed Capital LLC. Advisors and Genesis each reported 314,409 shares, or 2.3%, with shared voting and dispositive power; Capital reported 161,395 shares, or 1.2%, with sole voting and dispositive power. The reporting persons said they held 3.5% of the common stock on behalf of other persons entitled to direct dividends or sale proceeds. Carl L. Gordon, W. Carter Neild and Geoffrey C. Hsu serve on the management committee exercising investment and voting power, and each disclaims beneficial ownership of the reported shares.

Beneficial ownership — OrbiMed Advisors LLC 314,409 shares 2.3% of the class; shared voting and dispositive power
Beneficial ownership — OrbiMed Genesis GP LLC 314,409 shares 2.3% of the class; shared voting and dispositive power
Beneficial ownership — OrbiMed Capital LLC 161,395 shares 1.2% of the class; sole voting and dispositive power
Shares held on behalf of other persons 3.5% The reporting persons said the other persons could direct dividends or sale proceeds
Beneficially Owned regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power 314,409.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 314,409.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IMUX shares did OrbiMed report owning?

OrbiMed Advisors LLC and OrbiMed Genesis GP LLC each reported beneficial ownership of 314,409 shares, or 2.3%. OrbiMed Capital LLC reported 161,395 shares, or 1.2%.

What percentage of IMUX shares did OrbiMed hold for other investors?

The reporting persons said they held 3.5% of Immunic common stock on behalf of other persons who had the right to receive or direct dividends or sale proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





4525EP101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



OrbiMed Advisors LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026
OrbiMed Genesis GP LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026
OrbiMed Capital LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026

Keep reading